Protesters crash the BIO conference to protest the delayed approval of a breast cancer drug.
The Scientist
Most Recent
The regulatory agency will allow early-stage breast cancer patients to try experimental drugs previously reserved for those with advanced disease.
One cancer researcher says that by focusing solely on stalling cancer growth, clinical trials are failing some potentially life-saving drugs that prevent metastasis.
From breast milk stem cells to bone repair, this year’s EB conference held a number of exciting advances that could one day be translated into therapies.
A flood of new discoveries has refined our definition of cancer stem cells. Now it’s up to human clinical trials to test if they can make a difference in patients.
Starvation paired with cancer drugs slowed or stopped unchecked cell growth in yeast and mouse models of cancer, outpacing or matching the isolated effects of chemo.
The cancer charity is embroiled in an argument over embryonic stem cell research.
A new study shows that breast cancers that become resistant to hormone therapy have different patterns of estrogen receptor binding.
The age at which BRCA carriers are diagnosed with breast cancer may depend on which parent contributed the mutation.
Researchers scan the molecules in spider venom for anti-cancer effects in tissue culture.
Follow The Scientist
Stay Connected with The Scientist
-
The Scientist Magazine
-
The Scientist Careers
-
Neuroscience Research Techniques
-
Genetic Research Techniques
-
Cell Culture Techniques
-
Microbiology and Immunology
-
Cancer Research and Technology
Current Issue
